Advance your cell, gene and immunotherapies towards commercial success

by Alexey Bersenev on July 31, 2015 · 0 comments

in conferences

Post to Twitter Send Gmail Post to LinkedIn

This is promotional post by Howard Choi

Learn to how to apply the cost-effective and efficient strategies you need to advance your cell, gene and immunotherapies towards commercial success by attending IBC’s Cell Therapy Bioprocessing & Commercialization meeting, held September 30 – October 2, 2015 in Alexandria, VA.

For full program details, download the brochure today at http://bit.ly/B15188SCA

KEYNOTE SPEAKERS
Translation of Regenerative Medicine
Julie G. Allickson, Ph.D., Wake Forest Institute for Regenerative Medicine

Building our Biological Future
Rob Carlson BioEconomy Capital

Overcoming Challenges for Engineered Autologous T Cell Therapy
Marc Better, Ph.D. Kite Pharma

CAR Therapy: The CD19 Paradigm and Beyond
Michel Sadelain, Memorial Sloan Kettering Cancer Center

Secure your seat today to attend this year’s meeting and learn alongside fellow developers and end-users as you collectively share ideas, solutions and lessons learned to:

  • Accelerate your path from concept to product by applying insightful and relevant strategies from 80+ industry thought-leading speakers across 7 focused tracks
  • Stay at the forefront of innovation by evaluating new technologies and cutting-edge data in the exhibit and poster hall
  • Jump start collaborations and partnerships through networking luncheons, private exhibit hall tours, evening cocktail receptions, interactive panel discussions and more

REGISTER TODAY AND RECEIVE A 20% DISCOUNT
Register online at http://bit.ly/B15188SCA with code B15188SCA to receive a 20% registration discount off the standard rate (new registrations only).

For general questions about the meeting, contact Howie Choi at hchoi@ibcusa.com

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: